FDA Adverse Event
Injury
Summary report: N
ENDOTAK RELIANCE
MDR report key: 3053223
·
Received April 11, 2013
Report
- Report Number
- 2124215-2013-05103
- Event Type
- Injury
- Date Received
- April 11, 2013
- Date of Event
- March 20, 2013
- Report Date
- March 20, 2013
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE LEAD REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS RIGHT VENTRICULAR (RV) LEAD, THE VENTRICLE WAS PERFORATED. THE PATIENT WAS STABILIZED AND THE PROCEDURE WAS COMPLETED. IT WAS NOTED THAT THE PACING THRESHOLDS WERE NOT MEASURED AGAIN THROUGH THE DEVICE AFTER THE PERFORATION WAS TREATED. THE DEVICE WAS PROGRAMMED WITH TACHY THERAPY OFF WHILE THE PATIENT WAS MONITORED IN THE HOSPITAL. IT WAS REPORTED THAT THE PATIENT WAS DOING WELL. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 155327 | ENDOTAK RELIANCE | NVY | CPI - DEL CARIBE | 0293 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| L| R |